Your browser doesn't support javascript.
loading
A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity.
Thiemann, Meinolf; Richards, David M; Heinonen, Karl; Kluge, Michael; Marschall, Viola; Merz, Christian; Redondo Müller, Mauricio; Schnyder, Tim; Sefrin, Julian P; Sykora, Jaromir; Fricke, Harald; Gieffers, Christian; Hill, Oliver.
Affiliation
  • Thiemann M; Apogenix AG, Heidelberg, Germany.
  • Richards DM; Apogenix AG, Heidelberg, Germany.
  • Heinonen K; Apogenix AG, Heidelberg, Germany.
  • Kluge M; Apogenix AG, Heidelberg, Germany.
  • Marschall V; Apogenix AG, Heidelberg, Germany.
  • Merz C; Apogenix AG, Heidelberg, Germany.
  • Redondo Müller M; Apogenix AG, Heidelberg, Germany.
  • Schnyder T; Apogenix AG, Heidelberg, Germany.
  • Sefrin JP; Apogenix AG, Heidelberg, Germany.
  • Sykora J; Apogenix AG, Heidelberg, Germany.
  • Fricke H; Apogenix AG, Heidelberg, Germany.
  • Gieffers C; Apogenix AG, Heidelberg, Germany.
  • Hill O; Apogenix AG, Heidelberg, Germany.
Front Oncol ; 8: 387, 2018.
Article in En | MEDLINE | ID: mdl-30298117
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2018 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2018 Document type: Article Affiliation country: Germany